Determinants of the adherence to therapeutic plan in elderly Spaniards, over 60 years of age;Determinantes del cumplimiento terapéutico en personas mayores de 60 años en España

Gaceta Sanitaria

Volumn 20, Issue 3, 2006, Pages 220-227

  Tuesca Molina, Rafael ^a   Guallar Castillón, Pillar ^b   Banegas Banegas, José Ramón ^b   Graciani Pérez Regadera, Auxiliadora ^b  

^a UNIVERSIDAD DEL NORTE   (Colombia)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Adherence; Elderly; Hypertension

Indexed keywords

EID: 33746336972     PISSN: 02139111     EISSN: None     Source Type: Journal    
DOI: 10.1157/13088853     Document Type: Article

References (39)

1. World Health Organization. Adherence to long-term therapies. Evidence for action. Ginebra: WHO; 2003.
2. Hamilton G.A. Measuring adherence in a hypertension clinical trial. Eur J Cardiovasc Nurs. 2003;2:219-28.
3. Anderson RT, Ory M, Cohen S, McBride JS. Issues of aging and adherence to health interventions. Control Clin Trials. 2000;21:171S-83S.
4. Nichols-English G, Poirier S. Optimising adherence to pharmaceutical care plans. J Am Pharm Assoc. 2000;40:475-85.
5. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. Compliance with antihypertensive therapy among elderly Medicaid enrolees: the role of age, gender and race. Am J. Public Health. 1996;86:1805-8.
6. Fischer MA, Avorn J. Economic implications of evidence-based prescribing for hypertension: can better care cost less? JAMA. 2004;291:1850-6.
7. Bayliss EA, Steiner JF, Fernald DH, Crane LA, Main DS. Descriptions of barriers to self-care by persons with comorbid chronic diseases. Ann Fam Med. 2003;1:15-21.
8. Grumbach K. Chronic illness, comorbidities, and the need for medical generalism. Ann Fam Mod. 2003;1:4-7.
9. Villar-Álvarez F, Banegas JR, Rodríguez-Artalejo F. Las enfermedades cardiovasculares y sus factores de riesgo en España: hechos y cifras. Madrid: ERGON; 2003.
10. Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-72.
11. Banegas JR. Epidemiología de la hipertensión arterial en personas mayores de 60 años en España. Madrid: Anales de la Real Academia Nacional de Medicina; 2002, p. 143-51.
12. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, et al. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ. 2004;328:634-40.
13. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67-74.
14. Encuesta Nacional de Salud de España 1997, Madrid: Ministerio de Sanidad y Consumo; 1999.
15. Gil-López E, Jiménez GP R, Pérez-Andrés C, Vargas-Marcos F. Estudio de los estilos de vida de la población adulta española. Madrid: Artegraf, S.A.; 1992.
16. Unitat de Recerca en Serveis Sanitaris. Manual de puntuación de la versión Española del cuestionario de Salud SF-36. Barcelona: Institut Municipal d'Investigació Mèdica; 1998.
17. España-Portugal. 21(990).2000. Poitiers-France, Michelin Ediciones. Ref type: Map.
18. Krousel M, Muntner P, Jannu A, Desalvo K, Re R. Reliability of a medication adherence measure in an outpatient setting. Am J Med Sci. 2005;330:128-33.
19. Poluzzi E, Strahinja P, Vargiu A, Chiabrando, G, Silvani MC, Motola D, et al. Initial treatment of hypertension and adherence to therapy in general practice in Italy. Eur J Clin Pharm. 2005;61:603-9.
20. Lowry K, Dudley T, Oddone E, Bosworth H. Intentional and unintentional nonadherence to antyhypertensive medication. Ann Pharm. 2005;39:1198-203.
21. Benavides F, Rodríguez M, Arjol A, Mas M, Rodríguez JJ, Tovar JL. Pacientes hipertensos mal controlados: variables relacionadas con el tiempo hasta modificar el tratamiento (estudio HIMOT: hipertensión y modificación del tratamiento). Hipertension. 2004;21:442-7.
22. Yiannakopoulou E, Papadopulos J, Cokkinos D, Mountokalakis T. Adherence to antihypertensive treatment: a critical factor for blood pressure control. Eur J Cardiovasc Prev Rehabil. 2005;12:243-9.
23. Wang P, Bohn RL, Knight E, Glynn RJ, Mogun H, Avorn J. Non compliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med. 2002;17:504-11.
24. Shea S, Misra D, Ehrlich MH, Field L, Francis CK. Correlates of nonadherence to hypertension treatment in an inner-city minority population. Am J Public Health. 1992;82: 1607-12.
25. Ogedegbe G, Mancuso CA, Allegrante JP, Charlson ME. Development and evaluation of a medication adherence self-efficacy scale in hypertensive African-American patients. J Clin Epidemiol. 2003;56:520-9.
26. Salzman C. Medication compliance in the elderly. J Clin Psychiatry. 1995;56 Suppl 1:18-22.
27. Du X. Prevalence, treatment, control, and awareness of high blood pressure and the risk of stroke in Northwest England. Prev Med. 2000;30:288-94.
28. Reynolds K, Gu D, Muntner P, Wu X, Chen J, Huang G, et al. Geographic variations in the prevalence, awareness, treatment and control of hypertension in China. J Hypertens. 2003;21:1273-81.
29. Egan BM, Lackland DT, Cutler NE. Awareness, knowledge, and attitudes of older Americans about high blood pressure: implications for health care policy, education, and research. Arch Intern Med. 2003;163:681-7.
30. Pan WH, Chang HY, Yeh WT, Hsiao SY, Hung YT. Prevalence, awareness, treatment and control of hypertension in Taiwan: results of Nutrition and Health Survey in Taiwan (NAHSIT) 1993-1996. J Hum Hypertens. 2001;15:793-8.
31. Clark MJ, Curran C, Noji A. The effects of community health nurse monitoring on hypertension identification and control. Public Health Nursing. 2000;17:452-9.
32. De Henauw S, De Bacquer D, Fonteyne W, Stam M, Kornitzer M, De Backer G. Trends in the prevalence, detection, treatment and control of arterial hypertension in the Belgian adult population. J Hypertens. 1998;16:277-84.
33. Tedesco MA, Di Salvo G, Caputo S, Natale F, Ratti G, Iarussi D, et al. Educational level and hypertension: how socioeconomic differences condition health care. J Hum Hypertens. 2001;15:727-31.
34. Oliveira TC, Araujo TL. Mecanismos desenvolvidos por idosos para enfrentar a hipertensâo arterial. Rev Esc Enferm USP. 2002; 36:276-81.
35. Coca A, Evolución del control de la hipertensión arterial en atención primaria en España. Resultados del estudio Controlpres 2003. Hipertensión. 2005;22:5-14.
36. Nuesch R, Schroeder K, Dieterle T, Martina B, Battegay E. Relation between insufficient response to antihypertensive treatment and poor compliance with treatment: a prospective case-control study. BMJ. 2001;323:142-6.
37. Banegas JR, Rodríguez-Artalejo F, Graciani Pérez-Regadera A, De la Cruz-Troca JJ, Villar-Álvarez F. Beneficios potenciales del control de la hipertensión. Hipertensión. 2002; 19:19-27.
38. Landenpera T, Kyngas H. Levels of compliance shown by hypertensive patients and their attitude toward their illness. J Adv Nur. 2001;34:189-95.
39. Coca A. Grado de control de la hipertensión arterial en España: ¿dónde estamos? Hipertensión. 2004; 21:385-7.